Back to News
Market Impact: 0.18
Epitel’s REMI Neuro Monitoring System Selected for the FDA’s READI-Home Innovation Challenge
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
Epitel will engage with the FDA to explore home-use applications for its REMI wireless EEG system, aimed at extended-duration neurological monitoring. The initiative could expand REMI's use in epilepsy and other remote-monitoring settings, but no approval, timeline, or financial impact was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- How the US midterm elections reflected resistance to data centres
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI Party isn't Ending Because Of The Blue Wave Says Ives
- SoftBank, ABB consider China carve-out to rescue $5.4bn robotics deal
- A ‘geologic freak’ called the Smackover may end America’s lithium dependence on China, and Big Oil is already there
- AI’s Grip on Financial Markets Was Never Clearer on the Way Down